Receipt of recommended adolescent vaccines among youth with special health care needs

Annie-Laurie McRee, Gary R. Maslow, Paul L. Reiter

    Research output: Contribution to journalArticlepeer-review

    7 Scopus citations


    We examined vaccination coverage among youth with special health care needs (YSHCN) using data from parents of adolescents (11-17 years) who responded to a statewide survey in 2010-2012 (n = 2156). Using a validated screening tool, we identified 29% of adolescents as YSHCN. Weighted multivariable logistic regression assessed associations between special health care needs and receipt of tetanus booster, meningococcal, and human papillomavirus (HPV) vaccines. Only 12% of youth had received all 3 vaccines, with greater coverage for individual vaccines (tetanus booster, 91%; meningococcal, 32%; HPV, 26%). YSHCN had greater odds of HPV vaccination than other youth (33% vs 23%, OR = 1.70, 95% CI = 1.16-2.50) but vaccination coverage was similar (P ≥.05) for other outcomes. In subgroup analyses, HPV vaccination also differed depending on the number and type of special health care needs identified. Findings highlight low levels of vaccination overall and missed opportunities to administer recommended vaccines among all youth, including YSHCN.

    Original languageEnglish (US)
    Pages (from-to)451-460
    Number of pages10
    JournalClinical Pediatrics
    Issue number5
    StatePublished - May 1 2017

    Bibliographical note

    Funding Information:
    The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by grant R40MC28313, MCH Research Program, from the Maternal and Child Health Bureau (Title V, Social Security Act), Health Resources and Services Administration, US Department of Health and Human Services.

    Funding Information:
    The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: ALM served on the Coalition for Meningococcal B Vaccine for Pfizer, Inc. PLR has received HPV vaccine-related grants from Merck Sharp & Dohme Corp and from Cervical Cancer-Free America whose funding came from an unrestricted educational grant from GlaxoSmithKline. These funds were not used to support this research study. GRM has no disclosures to report.

    Publisher Copyright:
    © The Author(s) 2016.


    • Adolescent
    • Health status disparities
    • Immunization
    • Special health care needs
    • Vaccination


    Dive into the research topics of 'Receipt of recommended adolescent vaccines among youth with special health care needs'. Together they form a unique fingerprint.

    Cite this